Last checked at 10 Nov 2017 16:04
10th November 2017
N4 Pharma plc (the "Company")
Notification of Transaction by Directors/PDMRs
The Company was notified on 10th November 2017 that a Person Discharging Management Responsibilities ("PDMR"), had purchased shares in the Company as set out below. Following this purchase, Nigel Theobald now has a total beneficial interest in 12,255,233 Ordinary Shares, representing 16.4% of the issued share capital of the Company.
The Company's share capital consists of 74,714,285 Ordinary Shares with voting rights.
1 | Details of the person discharging managerial responsibilities/person closely associated | ||
a) |
Name |
Nigel Theobald | |
2 | Reason for the notification | ||
a) |
Position/status | CEO and Director | |
b) |
Initial notification/ Amendment | Initial notification | |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
a) |
Name
| N4 Pharma Plc | |
b) |
LEI | 213800I841D2RKMFK955 | |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) |
Description of the financial instrument, type of instrument Identification code | Oridinary shares BGP 0.0004
ISIN code GB00BYW8QM32
| |
b) |
Nature of the transaction | Direct purchase of shares | |
c) |
Price(s) and volume(s)
| Price | volume |
£0.07925 | 56,656 | ||
d) | Aggregated information - Aggregated price - Aggregated volume - Aggregated total | n/a | |
e) |
Date of the transaction | 10th November 2017 | |
f) |
Place of the transaction | London Stock Exchange, AIM | |
g) | Additional Information |
| |